Clinical Trials Insight: 700056504
Phase of Trial: Phase I
Latest Information Update: 26 May 2010
At a glance
- Drugs AM 461 (Primary)
- Indications Allergic rhinitis; Asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Amira Pharmaceuticals
- 26 May 2010 Status changed from recruiting to completed, according to an Amira Pharmaceuticals media release.
- 03 Dec 2009 New trial record.